'But they are getting hit very very hard. So many people are dying in that mess.'
Where, when and how to watch it from the UK.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
With the US joining Israel in strikes on Iran, we take a look at where you might want to head if the conflict escalates.